First half of 2021: Boehringer Ingelheim makes fundamental progress in research and development

Retrieved on: 2021-08-03 08:03:45

Tags for this article:

Click the tags to see associated articles and topics

First half of 2021: Boehringer Ingelheim makes fundamental progress in research and development. View article details on hiswai:

Excerpt

The company's success is based on its rich R&D portfolio with a focus on diseases with high unmet medical need. The R&D pipeline in Human Pharma ...

Article found on: www.galvnews.com